Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients have?
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients has 84 citations in the OpenAlex counts ScholarIQ stores.
When was Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients published?
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients has 2019 year in the ScholarIQ index.
What is the open-access status of Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients?
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients has green oa status in the ScholarIQ index.
What is the DOI of Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients?
The DOI for Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients is on the source record.
What is the PMID of Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients?
The PMID for Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients is on the source record.
What is the OpenAlex record for Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients?
The OpenAlex for Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients is on the source record.